Selective Photodepletion of Recipient-Alloreactive T-Cells Enables Safe and Efficacious Haploidentical HSCT: Initial Results from a Phase 2 Trial in Patients with AML, ALL, and MDS

被引:7
|
作者
Roy, Denis-Claude [1 ]
Maertens, Johan [2 ]
Walker, Irwin [3 ]
Lachance, Silvy [1 ]
Roy, Jean [1 ]
Foley, Stephen Ronan [3 ]
Lewalle, Philippe [4 ]
Selleslag, Dominik L. D. [5 ]
De Jong, Liesbeth [6 ]
Velthuis, Jurjen H. L. [6 ]
Gerez, Lisya [6 ]
Reitsma, Karen [6 ]
Wagena, Edwin [6 ]
Mielke, Stephan [7 ]
机构
[1] Univ Montreal, Hop Maisonneuve Rosemont, Montreal, PQ, Canada
[2] Univ Hosp Gasthuisberg Leuven, Leuven, Belgium
[3] Juravinski Hosp & Canc Ctr, Hamilton, ON, Canada
[4] ULB, Inst Jules Bordet, Brussels, Belgium
[5] Acad Hosp St Jan, Brugge, Belgium
[6] Kiadis Pharma, Amsterdam, Netherlands
[7] Univ Klinikum Wurzburg, Wurzburg, Germany
关键词
D O I
10.1182/blood.V124.21.38.38
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:4
相关论文
共 8 条
  • [1] SELECTIVE PHOTODEPLETION OF RECIPIENT-ALLOREACTIVE T-CELLS ENABLES SAFE AND EFFICACIOUS HAPLOIDENTICAL HSCT: INTERIM RESULTS FROM A PHASE II TRIAL IN PATIENTS WITH AML, ALL, AND MDS
    Roy, D. -C.
    Maertens, J.
    Walker, I.
    Foley, R.
    Lewalle, P.
    Selleslag, D.
    Velthuis, J.
    Gerez, L.
    Reitsma, K.
    Wagena, E.
    Roy, J.
    Lachance, S.
    Mielke, S.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S221 - S221
  • [2] SELECTIVE DEPLETION OF RECIPIENT-ALLOREACTIVE T-CELLS WHILE RETAINING VIRAL-SPECIFIC AND MEMORY T-CELLS ENABLES SAFE AND EFFICACIOUS HAPLO-IDENTICAL HSCT
    Velthuis, J.
    De Jong, L.
    Boumedine, R. S.
    Giard, M.
    Roy, D.
    Ruediger, M.
    CYTOTHERAPY, 2014, 16 (04) : S19 - S19
  • [3] Selective Depletion of Recipient-Alloreactive T-Cells While Retaining Viral-Specific and Memory T-Cells Enables Safe and Efficacious Haplo-Identical HSCT
    Velthuis, Jurjen H. L.
    De Jong, Liesbeth
    Boumedine, Radia Sidi
    Giard, Marie-Pier
    Roy, Denis-Claude
    Ruediger, Manfred
    BLOOD, 2014, 124 (21)
  • [4] SELECTIVE DEPLETION OF RECIPIENT-ALLOREACTIVE T-CELLS WHILE RETAINING VIRAL-SPECIFIC AND MEMORY T-CELLS ENABLES SAFE AND EFFICACIOUS HAPLO-IDENTICAL HSCT
    Velthuis, J.
    De Jong, L.
    Boumedine, R. Sidi
    Giard, M. -P.
    Roy, D. -C.
    Ruediger, M.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S127 - S128
  • [5] Donor lymphocytes depleted of alloreactive T-cells (ATIR101) improve overall survival and reduce transplant related mortality in a T-cell depleted haploidentical HSCT: Results from a Phase 2 trial in patients with AML and ALL
    Roy, D. -C.
    Lachance, S.
    Roy, J.
    Walker, I.
    Maertens, J.
    Cohen, S.
    Foley, S. R.
    Lewalle, P.
    Olavarria, E.
    Selleslag, D.
    Ruediger, M.
    Velthuis, J.
    Reitsma, K.
    Gerez, L.
    Rovers, J.
    Boenig, H.
    Mielke, S.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S27 - S28
  • [6] Donor Lymphocytes Depleted of Alloreactive T-Cells (ATIR101) Improve Event-Free Survival (GRFS) and Overall Survival in a T-Cell Depleted Haploidentical HSCT: Phase 2 Trial in Patients with AML and ALL
    Roy, Denis-Claude
    Lachance, Silvy
    Roy, Jean
    Walker, Irwin
    Maertens, Johan
    Delisle, Jean-Sebastien
    Foley, Stephen Ronan
    Lewalle, Philippe
    Olavarria, Eduardo
    Selleslag, Dominik
    Ruediger, Manfred
    Velthuis, Jurjen
    Gerez, Lisya
    Rovers, Jeroen
    Bonig, Halvard
    Mielke, Stephan
    BLOOD, 2016, 128 (22)
  • [7] IMMUNOTHERAPY WITH DONOR LYMPHOCYTES DEPLETED OF ANTI-HOST REACTIVE CELLS RESULTS IN SAFE AND EFFICACIOUS HAPLOIDENTICAL HSCT: INTERIM RESULTS FROM A PHASE II TRIAL IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
    Roy, D.
    Maertens, J.
    Walker, I.
    Foley, R.
    Lewalle, P.
    Selleslag, D.
    Velthuis, J.
    Gerez, L.
    Reitsma, K.
    Wagena, E.
    Roy, J.
    Lachance, S.
    Mielke, S.
    CYTOTHERAPY, 2014, 16 (04) : S27 - S27
  • [8] Donor Lymphocytes Depleted of Alloreactive T-Cells (ATIR101) Reduce Transplant Related Mortality and Improve Overall Survival in Haploidentical HSCT for Patients with AML and ALL, Using an Immunosuppressant-Free Transplant Regimen
    Roy, Denis-Claude
    Lachance, Silvy
    Roy, Jean
    Walker, Irwin
    Maertens, Johan
    Cohen, Sandra
    Foley, Stephen Ronan
    Lewalle, Philippe
    Olavarria, Eduardo
    Selleslag, Dominik
    Rudiger, Manfred
    Velthuis, Jurjen
    Reitsma, Karen
    Gerez, Lisya
    Rovers, Jeroen
    Bonig, Halvard
    Mielke, Stephan
    BLOOD, 2015, 126 (23)